Actively Recruiting

Age: 18Years +
All Genders
NCT04776642

Biobank for "Arrhythmia and Conduction Disorders: TowArd Pathophysiology Based Treatment"

Led by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Updated on 2024-01-25

1000

Participants Needed

1

Research Sites

784 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The 'ADAPT' Biobank is a collection of body material and data from patients with or at risk of cardiac arrhythmias who underwent or will undergo (non-) invasive treatment for this disease. Its main objective is to obtain a comprehensive collection of patient information and material to facilitate research and gain better insight into the complex pathophysiology of the different arrhythmias, the multifactorial process, the heterogeneity in clinical presentation, and prognosis. Bodily material is used for biochemical marker assessments, histological and molecular analyses for research in cardiac arrhythmias.

CONDITIONS

Official Title

Biobank for "Arrhythmia and Conduction Disorders: TowArd Pathophysiology Based Treatment"

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients visiting the AMC outpatient clinic
  • Patients included in an ongoing clinical trial linked to this biobank (such as MARK AF, INDICO AF, PREDICT AF, WEIGHTLOSS AF, MAD AF)
  • Patients included in future clinical trials linked to this biobank investigating cardiac arrhythmias
  • Patients with cardiac arrhythmias including supraventricular tachycardia (atrial fibrillation, atrial tachycardia, atrial flutter, AVNRT, AVRT), ventricular tachycardia (ventricular tachycardia, ventricular flutter, ventricular fibrillation), bradycardia (sinus node dysfunction, AV node dysfunction, interventricular conduction disorder), or arrhythmogenic cardiomyopathies (dilated, restrictive, ARVC)
Not Eligible

You will not qualify if you...

  • Age under 18 years
  • Unable or unwilling to comply with study procedures
  • Pregnancy or childbearing potential without adequate contraception
  • NYHA class IV heart failure symptoms or left ventricular ejection fraction less than 35%

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Amsterdam University Medical Center location AMC

Amsterdam, Netherlands

Actively Recruiting

Loading map...

Research Team

E

Elise Hulsman, Bc RN

CONTACT

J

Joris de Groot, MD, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

7

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here